Evidence map›Paper›PMID 30994900›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Impact of Abstinence and of Reducing Illicit Drug Use Without Abstinence on Human Immunodeficiency Virus Viral Load.

Robin M Nance, Maria Esther Perez Trejo, Bridget M Whitney, Joseph A C Delaney, Fredrick L Altice, Curt G Beckwith, Geetanjali Chander, Redonna Chandler, Katerina Christopoulous, Chinazo Cunningham and 23 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Overamped: Stimulant Use and HIV Pathogenesis.Current HIV/AIDS reports · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Robin M NanceDepartment of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
Maria Esther Perez TrejoDepartment of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
Bridget M WhitneyDepartment of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
Joseph A C DelaneyDepartment of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
Fredrick L AlticeDepartment of Medicine, Yale University School of Medicine, New Haven, Connecticut.
Curt G BeckwithDepartment of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island.
Geetanjali ChanderDivision of General Internal Medicine, Johns Hopkins University, Baltimore, Maryland.
Redonna ChandlerNational Institute on Drug Abuse, Bethesda, Maryland.
Katerina ChristopoulousDepartment of Medicine, University of California-San Francisco.
Chinazo CunninghamDepartment of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
William E CunninghamDepartment of Medicine, University of California-Los Angeles.
Carlos Del RioDepartment of Global Health, Emory University, Atlanta, Georgia.
Dennis DonovanDepartment of Psychiatry, University of Washington, Seattle.
Joseph J EronDepartment of Medicine, University of North Carolina, Chapel Hill.
Rob J FredericksenDepartment of Medicine, University of Washington, Seattle.
Shoshana KahanaNational Institute on Drug Abuse, Bethesda, Maryland.
Mari M KitahataDepartment of Medicine, University of Washington, Seattle.
Richard KronmalDepartment of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
Irene KuoDepartment of Epidemiology, George Washington University, Washington, DC.
Ann KurthSchool of Nursing, Yale University School of Medicine, New Haven, Connecticut.
W Chris MathewsDepartment of Medicine, University of California-San Diego, UCSD Medical Center.
Kenneth H MayerHarvard Medical School, Fenway Institute, Boston, Maryland.
Richard D MooreDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland.
Michael J MugaveroDepartment of Medicine, University of Alabama-Birmingham.
Lawrence J OuelletUniversity of Illinois-Chicago.
Vu M QuanCenters for Disease Control and Prevention, Atlanta, Georgia.
Michael S SaagDepartment of Medicine, University of Alabama-Birmingham.
Jane M SimoniDepartment of Psychology, University of Washington, Seattle.
Sandra SpringerDepartment of Medicine, Yale University School of Medicine, New Haven, Connecticut.
Lauren StrandDepartment of Biostatistics, University of Washington, Collaborative Health Studies Coordinating Center, Seattle.
Faye TaxmanDepartment of Criminology, George Mason University, Fairfax, Virginia.
Jeremy D YoungUniversity of Illinois-Chicago.
Heidi M CraneDepartment of Medicine, University of Washington, Seattle.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI E. Jennifer Edelman · 2001 to 2026
$48.5M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIVR01DA032083 · NIDA · NEW YORK UNIVERSITY · PI GWADZ, MARYA · 2011 to 2015
$7.5M
RCT of an augmented test, treat, link, & retain model for NC and Texas prisonersR01DA030793 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLYNN, PATRICK M, GOLIN, CAROL E · 2010 to 2015
$6.9M
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSMR01DA032106 · NIDA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DUERR, ANN C · 2011 to 2015
$6.6M
Integrated Care Clinics for IDUs in India: a cluster randomized trialR01DA032059 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M, MEHTA, SHRUTI H · 2011 to 2015
$6.3M
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine UsersR01DA032098 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DEL RIO, CARLOS, METSCH, LISA R · 2011 to 2015
$6.2M
NHLBI NIH HHS R01 HL126538NIAAA NIH HHS U01 AA020793NIAAA NIH HHS U01 AA020802NIAAA NIH HHS U24 AA020801NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI094189NIAID NIH HHS R24 AI067039NIDA NIH HHS R01 DA030747NIDA NIH HHS R01 DA030762NIDA NIH HHS R01 DA030766NIDA NIH HHS R01 DA030768NIDA NIH HHS R01 DA030770NIDA NIH HHS R01 DA030771NIDA NIH HHS R01 DA030776NIDA NIH HHS R01 DA030778NIDA NIH HHS R01 DA030781NIDA NIH HHS R01 DA030793NIDA NIH HHS R01 DA032057NIDA NIH HHS R01 DA032059NIDA NIH HHS R01 DA032061NIDA NIH HHS R01 DA032080NIDA NIH HHS R01 DA032082NIDA NIH HHS R01 DA032083NIDA NIH HHS R01 DA032098NIDA NIH HHS R01 DA032100NIDA NIH HHS R01 DA032106NIDA NIH HHS R01 DA032110NIDA NIH HHS R01 DA047045NIDA NIH HHS R34 DA035728NIDA NIH HHS U01 DA036935NIDA NIH HHS U01 DA037702NIMH NIH HHS P30 MH062294NIMH NIH HHS R01 MH094090
6 · The paper itself

Abstract

backgroundSubstance use is common among people living with human immunodeficiency virus (PLWH) and a barrier to achieving viral suppression. Among PLWH who report illicit drug use, we evaluated associations between HIV viral load (VL) and reduced use of illicit opioids, methamphetamine/crystal, cocaine/crack, and marijuana, regardless of whether or not abstinence was achieved.

methodsThis was a longitudinal cohort study of PLWH from 7 HIV clinics or 4 clinical studies. We used joint longitudinal and survival models to examine the impact of decreasing drug use and of abstinence for each drug on viral suppression. We repeated analyses using linear mixed models to examine associations between change in frequency of drug use and VL.

resultsThe number of PLWH who were using each drug at baseline ranged from n = 568 (illicit opioids) to n = 4272 (marijuana). Abstinence was associated with higher odds of viral suppression (odds ratio [OR], 1.4-2.2) and lower relative VL (ranging from 21% to 42% by drug) for all 4 drug categories. Reducing frequency of illicit opioid or methamphetamine/crystal use without abstinence was associated with VL suppression (OR, 2.2, 1.6, respectively). Reducing frequency of illicit opioid or methamphetamine/crystal use without abstinence was associated with lower relative VL (47%, 38%, respectively).

conclusionsAbstinence was associated with viral suppression. In addition, reducing use of illicit opioids or methamphetamine/crystal, even without abstinence, was also associated with viral suppression. Our findings highlight the impact of reducing substance use, even when abstinence is not achieved, and the potential benefits of medications, behavioral interventions, and harm-reduction interventions.

Indexed as

HIV InfectionsIllicit DrugsSubstance-Related DisordersHIVHumansLongitudinal StudiesViral LoadIllicit Drugsabstinencedrug useheroinsubstance useviral suppression

Identifiers

PMID30994900
PMCPMC7319266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.